Drug Type Gene therapy, Cell therapy |
Synonyms- |
Target- |
Mechanism Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 1 | CN | 26 Apr 2019 |
Not Applicable | - | (bftuxqjulk): HR = 0.71 (95% CI, 0.58 - 0.87), P-Value = 0.001 View more | Positive | 21 Oct 2023 | |||